Global 3D Bioprinting Equipment Market Professional Survey Report 201 Blood-Clotting-Factor-VIII-Market-Report-2017 | Page 4

6.9.2.2 Product B
6.9.3 Ferring Blood Clotting Factor VIII Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Janssen
6.10.2 Blood Clotting Factor VIII Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Janssen Blood Clotting Factor VIII Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 NeuroDerm
6.12 Octapharma
6.13 Roche
6.14 Rhythm Metabolic
7 Blood Clotting Factor VIII Manufacturing Cost Analysis
7.1 Blood Clotting Factor VIII Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Blood Clotting Factor VIII
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Blood Clotting Factor VIII Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Blood Clotting Factor VIII Major Manufacturers in 2015
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change